SCHEMBL3598121

SCHEMBL3598121

O=C(Cn1ccc2cccc([N+](=O)[O-])c21)NCCNCC1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
ALDH1A1 P00352 5/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPK1 P28482 2/20 0.39
NPY5R Q15761 2/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 3/20 0.36
TSHR P16473 2/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
EPHX2 P34913 1/20 0.35
NPC1 O15118 1/20 0.35
ALOX15 P16050 1/20 0.35
MEN1 O00255 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585615 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10MAPK1NPY5RKMT2A
SCHEMBL3591246 0.84 LMNA (0.46) ALDH1A1HSD17B10MAPK1NPY5RKMT2A
SCHEMBL3586422 0.83 NPY5R (0.42) POLBALDH1A1HSD17B10MAPK1NPY5R
SCHEMBL3598118 0.82 ALDH1A1 (0.38) ALDH1A1HSD17B10MAPK1KMT2AKDM4E
SCHEMBL3598036 0.81 HPGD (0.47) POLBALDH1A1HSD17B10MAPK1NPY5R
SCHEMBL3597289 0.81 ALDH1A1 (0.41) ALDH1A1HSD17B10MAPK1NPY5RKMT2A
SCHEMBL3595022 0.79 HSD17B10 (0.55) ALDH1A1HSD17B10MAPK1NPY5RKMT2A
SCHEMBL3594707 0.79 NPC1 (0.41) ALDH1A1HSD17B10MAPK1NPY5RKMT2A
SCHEMBL3608260 0.79 GRIN2B (0.42) POLBALDH1A1HSD17B10MAPK1NPY5R
SCHEMBL3608180 0.79 HTT (0.45) ALDH1A1HSD17B10MAPK1NPY5RKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed
WO-2007115231-A2 CXCR4 MODULATORS CHEMOCENTRYX, INC. (US) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 POLB 4479/4885ALDH1A1 662/4885HSD17B10 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.